Nanotech for Neurological Health: Nasal Gel Innovations | InformativeBD

 

Indira Muzib Yallamalli , Arunakumari Dommaraju , and Ramji Ambedkar Yellamelli from the different institute of the india wrote a research article about Nanotech for Neurological Health: Nasal Gel Innovations, entitled " Intra nasal in-situ gel freighted with Nano naturaceuticals for neurological diseases – from bench to bed side"This research paper published by the International Journal of Bioscience |IJB an open access scholarly research journal on Biology, under the affiliation of the International Network For Natural Sciences |INNSpub, an open access multidisciplinary research journal publisher.

Abstract:

The treatment for acute or chronic neurodegenerative diseases is the most exigent aspect in many aspects, as the drug should cross the blood-brain barrier. At present many formulations have been developed for synthetic drugs to target the drug to the brain through various routes. Among them,the nasal route is one of the most prominent routes to target the drug to the brain, where the drug can bypass the BBB. There are many natural drugs, Phytoconstituents also available for the treatment of neurodegenerative diseases. Because of the many advantages like natural, safe, easily available, biocompatible, low cost, etc., of natural drugs over synthetic drugs, the researchers were focused on the development of the formulations of natural drugs for various diseases. But here, the challenging concept is the delivery of the active Phytoconstituents to the brain through the nasal route as the molecular weight of the drugs is rate limited. Among the nasal formulations, in-situ gel systems are the trending research work carrying. So the review was focused on the overview of the available Phytoconstituents to treat brain disorders and how the drugs target the brain through the nasal route. A brief about nasal anatomy, the pros and cons of nasal drug delivery and nasal in-situ gels was also noted. The review summarizes the available nanoformulations for the Phytoconstituents to target the drug to the brain through the nasal route.

Read more :  Urban Noise and Bird Diversity: COVID-19Lockdown Impact | InformativeBD

Introduction:

Brian is a mesmerizing organ known for itsentanglement. This fragile organ was protected by theskull structure outside and inside,which consists ofmainly two protective barriers, namely the bloodbrainbarrier (BBB) and the blood-cerebro spinal fluidbarrier (BCSF), which hinder the treatment strategiesendorsed for the therapeutic determination. Becauseof this fragility, the time period will be more for thedevelopment of CNS drugs than the NON-CNS drugs(Dong, 2018). The CNS disorders such as epilepsy,dementia, Parkinson's, Alzheimer's, brain tumors,meningitis, and brain tumors, can be managed byboth natural and unnatural drug molecules butgreatly depends upon the means of attaining higherdrug levels at the targeting sites (Goyal D et al.,2017).However, the synthetic drug molecules havealow molecular weight compared to the natural onesand the research was expanded.

Presently the research on natural drugs is gainingmuch interest because of their bio-friendly nature andsupremacy over synthetic drugs (Borris, R. P. 1996).Most natural molecules havea high molecular weight,so the physico chemical properties of the drug mainlydomineer its ability to penetrate the drug throughthese barriers and to exhibit therapeutic outcomes(Yu et al., 2019). So the only option to target the drugmolecules inthe brain is bypassing the barriers. Tobypass the drug molecules through these protectivebarriers of brain to present their therapeutic effect,the nasal route drug delivery is the only choice (Khanet al., 2017). There is scientific growth supportingnasal drug delivery owing to the fact that a confirmedconcentration of drug can cross BBB. One moresatisfaction of this route is that it deliversboth intracellularand extra-cellular drug transport pathways tothe CNS, which further depends on added factors likephysico chemical properties of the drug and receptorspresent in the olfactory region.

Reference:

Abdou HM, Yousef MI, El Mekkawy DA. and Al-Shami AS. 2016. Prophylactic neuroprotective efficiency of co-administration of Ginkgo biloba and Trifolium pretense against sodium arsenite-induced neurotoxicity and dementia in different regions of brain and spinal cord of rats. Food and chemical toxicology 94, 112-127.

Ahirrao M, Shrotriya S. 2017. In vitro and in vivo evaluation of cubosomalin situ nasal gel containing resveratrol for brain targeting. Drug development and industrial pharmacy 43, 1686-1693.

Ahmad N. 2017. Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson’s disease. Journal of Liquid Chromatography & Related Technologies 40, 677-690. https://doi.org/10.1080/10826076.2017.1343735

Ahmad N, Ahmad R, Ahmad FJ, Ahmad W, Alam MA, Amir M, Ali A. 2020. Poloxamer-chitosan-based Naringenin nanoformulation used in brain targeting for the treatment of cerebral ischemia. Saudi Journal of Biological Sciences 27, 500-517. https://doi.org/10.1016/j.sjbs.2019.11.008

Allison AC, Cacabelos R, Lombardi VR, Álvarez XA, Vigo C. 2001. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer’s disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25, 1341-1357.

Arun Raj R, Murali A. 2019. Formulation and Evaluation of Curcumin Loaded Transferosomal Nasal In-Situ Gel for Alzheimer’s Disease. Res Rev AJ Drug Formul Dev Prod 6, 19-31.

Balakrishnan P, Park EK, Song CK, Ko HJ, Hahn TW, Song KW, Cho HJ. 2015. Carbopol-incorporated thermoreversible gel for intranasal drug delivery. Molecules 20, 4124-4135. https://doi.org/10.3390/molecules20034124

Bastianetto S, Ramassamy C, Doré S, Christen Y, Poirier J, Quirion R. 2000. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β amyloid. European Journal of Neuroscience 12, 1882-1890. https://doi.org/10.1046/j.1460-9568.2000.00069.x

Basu S, Bandyopadhyay AK. 2010. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech 11, 1223-1231. https://doi.org/10.1208/s12249-010-9477-x

Bertelli AA, Migliori M, Panichi V, Longoni B, Origlia N, Ferretti A, Cuttano MG, Giovannini L. 2002. Oxidative stress and inflammatory reaction modulation by white wine. Annals of the New York Academy of Sciences 957, 295-301. https://doi.org/10.1111/j.1749-6632.2002.tb02929.x

Bertram, U, Bodmeier R. 2012. Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts. Drug development and industrial pharmacy 38, 659-669. https://doi.org/10.3109/03639045.2011.598536

Bhatnagar M, Sharma D, Salvi M. 2009. Neuroprotective effects of Withaniasomniferadunal.: a possible mechanism. Neurochemical research 34, 1975-1983. https://doi.org/10.1007/s11064-009-9987-7

Bhattacharya SK, Satyan KS, Ghosal S. 1997. Antioxidant activity of glycowithanolides from Withaniasomnifera. Indian journal of experimental biology 35, 236-239.

Bihaqi SW, Singh AP, Tiwari M. 2011. In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian journal of pharmacology 43, 520.

Borris RP. 1996. Natural products research: perspectives from a major pharmaceutical company. Journal of ethnopharmacology 51, 29-38. https://doi.org/10.1016/0378-8741(95)01347-4

Bunyatyan ND, Kovtun EV, Samylina IA, Stepanova EF, Olefir YV, Korol LA, Prokofiev AB, Evteev VA, Bokov DO. 2019. Prospects for intranasal drug delivery systems with Ginkgo biloba in the treatment of cerebral circulatory disorders. Tropical Journal of Pharmaceutical Research 18, 2233-2240.

Chang XR, Wang L, Li J, Wu DS. 2016. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Brain Research 1642, 219-225. https://doi.org/10.1016/j.brainres.2016.03.010

Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH. 2003. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. European Journal of Pharmacology 473, 1-7. https://doi.org/10.1016/S0014-2999(03)01945-9

Choi MJ, Soottitantawat A, Nuchuchua O, Min SG, Ruktanonchai U. 2009. Physical and light oxidative properties of eugenol encapsulated by molecular inclusion and emulsion–diffusion method. Food Research International 42, 148-156. https://doi.org/10.1016/j.foodres.2008.09.011

Choudhary S, Kumar P, Malik J.  2013. Plants and phytochemicals for Huntington’s disease. Pharmacognosy reviews 7, 81.

Dhakar RC, Maurya SD, Tilak VK, Gupta AK.  2011. A review on factors affecting the design of nasal drug delivery system. International journal of drug delivery 3, 194.

Dhingra D, Parle M, Kulkarni. 2004. Memory enhancing activity of Glycyrrhiza glabra in mice. Journal of ethnopharmacology 91, 361-365. https://doi.org/10.1016/j.jep.2004.01.016

Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R. 2012. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine: Nanotechnology, Biology and Medicine 8, 440-451. https://doi.org/10.1016/j.nano.2011.07.011

Dong X. 2018. Current strategies for brain drug delivery. Theranostics 8, 1481.

Ehrick JD, Shah SA, Shaw C, Kulkarni VS, Coowanitwong I, De S, Suman JD. 2013. Considerations for the development of nasal dosage forms. Sterile Product Development, Springer: 99-144.

Gaba B, Khan T, Haider MF, Alam T, Baboota S, Parvez S Ali J. 2019. Vitamin E loaded naringenin nanoemulsion via intranasal delivery for the management of oxidative stress in a 6-OHDA Parkinson’s disease model. BioMed Research International 2019. https://doi.org/10.1155/2019/2382563

Gao H. 2016. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharmaceutica Sinica B 6, 268-286. https://doi.org/10.1016/j.apsb.2016.05.013

Gaysinsky S, Davidson PM, Bruce BD, Weiss J. 2005. Stability and antimicrobial efficiency of eugenol encapsulated in surfactant micelles as affected by temperature and pH. Journal of food protection 68, 1359-1366. https://doi.org/10.4315/0362-028X-68.7.1359

Ghaffari M, Dolatabadi JEN. 2019. Nanotechnology for pharmaceuticals. Industrial Applications of Nanomaterials, Elsevier: 475-502. https://doi.org/10.1016/B978-0-12-815749-7.00017-7

Gizurarso S. 1990. Animal models for intranasal drug delivery. Acta Pharm Nord 2, 105-122.

Goyal D, Shuaib S, Mann, S, Goyal B.2017. Rationally designed peptides and peptidomimetics as inhibitors of amyloid-β (Aβ) aggregation: potential therapeutics of Alzheimer’s disease. ACS combinatorial science 19, 55-80. https://doi.org/10.1021/acscombsci.6b00116

Grasdalen H, Smidsrød O. 1987. Gelation of gellan gum. Carbohydrate polymers 7, 371-393. https://doi.org/10.1016/0144-8617(87)90004-X

Gupta P, Siripurapu KB, Ahmad A, Palit G, Arora A, Maurya R. 2007. Anti-stress constituents of Evolvulusalsinoides: an ayurvedic crude drug. Chemical and Pharmaceutical Bulletin 55, 771-775.

Hao J, Zhao J, Zhang S, Tong T, Zhuang Q, Jin K, Chen W, Tang H. 2016. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Colloids and Surfaces B: Biointerfaces 147, 376-386. https://doi.org/10.1016/j.colsurfb.2016.08.011

Harrer, G, Schulz V. 1994. Clinical investigation of the antidepressant effectiveness of Hypericum. Journal of geriatric psychiatry and neurology 7, 6-8.

Ho YS, Yu MS, Yang XF, So KF, Yuen WH, Chang RCC. 2010. Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lyciumbarbarum, against homocysteine-induced toxicity in rat cortical neurons. Journal of Alzheimer’s disease 19, 813-827.

Illum L. 2002. Nasal drug delivery: new developments and strategies. Drug discovery today 7, 1184-1189. https://doi.org/10.1016/S1359-6446(02)02529-1

Jeong B, Kim SW, Bae YH. 2012. Thermosensitive sol–gel reversible hydrogels. Advanced drug delivery reviews 64, 154-162. https://doi.org/10.1016/j.addr.2012.09.012

Joseph JA, Shukitt-Hale B, Casadesus G. 2005. Reversing the deleterious effects of aging on neuronal communication and behavior: beneficial properties of fruit polyphenolic compounds. The American Journal of Clinical Nutrition 81, 313S-316S. https://doi.org/10.1093/ajcn/81.1.313S

Jussofie A, Schmiz A, Hiemke C. 1994. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 116, 469-474. https://doi.org/10.1007/BF02247480

Kanowski S, Herrmann WM, Stephan K, Wierich W, Hörr R. 1996. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29, 47-56.

Kapoor L. 1990. Handbook of Ayurvedic medicinal plants CRC Press Inc, Boca Raton, USA. Blackwell Science Ltd.

Khan AR, Liu M, Khan MW, Zhai G. 2017. Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, 364-389. https://doi.org/10.1016/j.jconrel.2017.09.001

Kim JH, Park EY, Ha HK, Jo CM, Lee WJ, Lee SS, Kim JW. 2016. Resveratrol-loaded nanoparticles induce antioxidant activity against oxidative stress. Asian-Australasian journal of animal sciences 29, 288.

Kim YH, Bae YH, Kim SW. 1994. PH/temperature-sensitive polymers for macromolecular drug loading and release. Advances in Drug Delivery Systems 6, 143-152.

Kundu A. 2016. An Overview on Neurodegenerative Diseases and Possible Leads from Natural Products. The Pharma Review 14, 66-70.

Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS, Suk K. 2003. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. The FASEB Journal 17, 1-21.

Li X, Du L, Chen X, Ge P, Wang Y, Fu Y, Sun H, Jiang Q, Jin Y. 2015. Nasal delivery of analgesic ketorolac tromethamine thermo-and ion-sensitive in situ hydrogels. International journal of pharmaceutics 489, 252-260. https://doi.org/10.1016/j.ijpharm.2015.05.009

Liu RH. 2003. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. The American Journal of Clinical Nutrition 78, 517S-520S. https://doi.org/10.1093/ajcn/78.3.517S

Liu R, Barkhordarian H, Emadi S, Park CB, Sierks MR. 2005. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42. Neurobiology of disease 20, 74-81. https://doi.org/10.1016/j.nbd.2005.02.003

Lopez-Lopez G, Moreno L, Cogolludo A, Galisteo M, Ibarra M, Duarte J, Lodi F, Tamargo J, Perez-Vizcaino F. 2004. Nitric oxide (NO) scavenging and no protecting effects of quercetin and their biological significance in vascular smooth muscle. Molecular pharmacology 65, 851-859. https://doi.org/10.1124/mol.65.4.851

Lindberg Madsen H, Møller Andersen C, Viborg Jørgensen L, Skibsted LH. 2000. Radical scavenging by dietary flavonoids. A kinetic study of antioxidant efficiencies. European Food Research and Technology 211, 240-246. https://doi.org/10.1007/s002170000189

Mahajan HS, Tyagi VK, Patil RR, Dusunge SB. 2013. Thiolated xyloglucan: Synthesis, characterization and evaluation as mucoadhesive in situ gelling agent. Carbohydrate polymers 91, 618-625.

Makwana SB, Patel VA, Parmar SJ. 2016. Development and characterization of in-situ gel for ophthalmic formulation containing ciprofloxacin hydrochloride. Results in pharma sciences 6, 1-6.

McDonough J, Dixon H, Ladika MJ. 2010. Nasal delivery of micro-and nano-encapsulated drugs. Handbook of non-invasive drug delivery systems, Elsevier: 193-208.

Mishra RK, Banthia AK, Majeed ABA. 2012. Pectin based formulations for biomedical applications: a review. Asian Journal of Pharmaceutical and Clinical Research 5, 1-7.

Mishra S, Srivastava S, Tripathi RD, Govindarajan R, Kuriakose SV Prasad MNV. 2006. Phytochelatin synthesis and response of antioxidants during cadmium stress in Bacopa monnieri L. Plant physiology and biochemistry 44, 25-37. https://doi.org/10.1016/j.plaphy.2006.01.007

Misra R. 1998. Modern drug development from traditional medicinal plants using radioligand receptor binding assays. Medicinal research reviews 18, 383-402.

Mohandas Rao KG, Muddanna Rao S, Gurumadhva Rao S. 2006. Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats. Evidence-Based Complementary and Alternative Medicine 3. https://doi.org/10.1093/ecam/nel024

Niranjan R, Koushik C, Saravanan S, Moorthi A, Vairamani M, Selvamurugan N. 2013. A novel injectable temperature-sensitive zinc doped chitosan/β-glycerophosphate hydrogel for bone tissue engineering. International journal of biological macromolecules 54, 24-29. https://doi.org/10.1016/j.ijbiomac.2012.11.026

Oi Y, Kawada T, Shishido C, Wada K, Kominato Y, Nishimura S, Ariga T, Iwai K,Oi Y, Kawada T, Shishido C, Wada K, Kominato Y, Nishimura S, Ariga T, Iwai K. 1999. Allyl-containing sulfides in garlic increase uncoupling protein content in brown adipose tissue, and noradrenaline and adrenaline secretion in rats. The Journal of nutrition 129, 336-342. https://doi.org/10.1093/jn/129.2.336

Olivier JC. 2005. Drug transport to brain with targeted nanoparticles. NeuroRx2, 108-119.

Ortiz JG, Nieves-Natal J, Chavez P. 1999. Effects of Valeriana officinalis extracts on [3 H] flunitrazepam binding, synaptosomal [3 H] GABA uptake, and hippocampal [3 H] GABA release. Neurochemical research 24, 1373-1378.

Pangeni R, Sharma S, Mustafa G, Ali J, Baboota S. 2014. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress. Nanotechnology 25, 485102.

Patel D, Patel D, Prajapati J, Patel U, Patel V. 2012. Formulation of thermoresponsive and buccal adhesive in situ gel for treatment of oral thrush containing poorlywater soluble drug bifonazole. Journal of pharmacy &bioallied sciences 4, S116.

Pires PC, Santos AO. 2018. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. Journal of Controlled Release 270, 89-100. https://doi.org/10.1016/j.jconrel.2017.11.047

Prediger RD, Fernandes MS, Rial D, Wopereis S, Pereira VS, Bosse TS, Da Silva CB, Carradore RS, Machado M.S, Cechinel-Filho V, Costa-Campos L. 2008. Effects of acute administration of the hydroalcoholic extract of mate tea leaves (Ilex paraguariensis) in animal models of learning and memory. Journal of ethnopharmacology 120, 465-473. https://doi.org/10.1016/j.jep.2008.09.018

Rajput A, Bariya A, Allam A, Othman S, Butan SB. 2018. In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization. Drug Delivery and Translational Research 8, 1460-1470.

Raut AA, Rege NN, Tadvi FM, Solanki PV, Kene KR, Shirolkar SG, Pandey SN, Vaidya RA, Vaidya AB. 2012. Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withaniasomnifera) in healthy volunteers. Journal of Ayurveda and integrative medicine 3, 111.

Renugadevi J, Prabu, SM. 2009. Naringenin protects against cadmium-induced oxidative renal dysfunction in rats. Toxicology 256, 128-134. https://doi.org/10.1016/j.tox.2008.11.012

Roney C, Kulkarni P, Arora V, Antich, P, Bonte F, Wu A, Mallikarjuana NN, Manohar S, Liang HF, Kulkarni AR, Sung HW. 2005. Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease. Journal of Controlled Release 108, 193-214.

Russo A, Borrelli F. 2005. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 12, 305-317.

Salem HF, Kharshoum RM, Abou-Taleb HA Naguib DM. 2019. Nanosized transferosome-based intranasal in situ gel for brain targeting of resveratrol: formulation, optimization, in vitro evaluation, and in vivo pharmacokinetic study. AAPS Pharmaceutical Scientists and Technology 20, 181.

Schliebs R, Liebmann A, Bhattacharya S.K, Kumar A, Ghosal S, Bigl V. 1997. Systemic administration of defined extracts from Withaniasomnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochemistry International 30, 181-190. https://doi.org/10.1016/S0197-0186(96)00025-3

Schultz V. 1998. Restless and sleep disturbances. Schultz V, Hansel R, Tyler VE. Rational Phytotherapy: A Physician’s Guide to Herbal Medicine. 3rd ed. Berlin: Springer-Verlag: 73-88.

Sherje AP, Londhe V. 2018. Development and evaluation of pH-responsive cyclodextrin-based in situ gel of paliperidone for intranasal delivery. AAPS PharmSciTech 19, 384-394.

Shinomol GK. 2008. Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. Neurotoxicology 29,948-957. https://doi.org/10.1016/j.neuro.2008.09.009

Shinomol GK, Mythri RB, Srinivas Bharath MM. 2012. Bacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brain. Cellular and molecular neurobiology 32, 455-465.

Sood S, Jain K, Gowthamarajan K. 2014. Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids and Surfaces B: Biointerfaces113, 330-337. https://doi.org/10.1016/j.colsurfb.2013.09.030

Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A. 2015. Resveratrol nanoformulations: challenges and opportunities. International journal of pharmaceutics 479, 282-290. https://doi.org/10.1016/j.ijpharm.2015.01.003

Teskač KJ, Kristl. 2010. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. International journal of pharmaceutics 390, 61-69. https://doi.org/10.1016/j.ijpharm.2009.10.011

Tsai YM, Chien CF, Lin LC, Tsai TH. 2011. Curcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetration. International journal of pharmaceutics 416, 331-338. https://doi.org/10.1016/j.ijpharm.2011.06.030

Umezu T, Nagano K, Ito H, Kosakai K, Sakaniwa M, Morita M. 2006. Anticonflict effects of lavender oil and identification of its active constituents. Pharmacology biochemistry and behavior85, 713-721. https://doi.org/10.1016/j.pbb.2006.10.026

Wang S, Chen P, Zhang L, Yang C, Zhai G. 2012. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin. Journal of drug targeting 20, 831-840. https://doi.org/10.3109/1061186X.2012.719230

Wang Y, Jiang S, Wang H, Bie H. 2017. A mucoadhesive, thermoreversiblein situ nasal gel of geniposide for neurodegenerative diseases.PloS one 12, e0189478. https://doi.org/10.1371/journal.pone.0189478

Werner U, Damge C, Maincent P, Bodmeier R. 2004. Properties of in situ gelling nasal inserts containing estradiol/methyl β-cyclodextrin. Journal of Drug Delivery Science and Technology 14, 275-284. https://doi.org/10.1016/S1773-2247(04)50048-5

Wu J, Wei W, Wang LY, Su ZG, Ma GH. 2007. A thermosensitive hydrogel based on quaternized chitosan and poly (ethylene glycol) for nasal drug delivery system. Biomaterials 28, 2220-2232. https://doi.org/10.1016/j.biomaterials.2006.12.024

Yanpallewar SU, Rai S, Kumar M, Acharya SB. 2004. Evaluation of antioxidant and neuroprotective effect of Ocimum sanctum on transient cerebral ischemia and long-term cerebral hypoperfusion. Pharmacology biochemistry and behavior 79, 155-164. https://doi.org/10.1016/j.pbb.2004.07.008

Yao ZX, Han Z, Drieu K, Papadopoulos V. 2004. Ginkgo biloba extract (Egb 761) inhibits β-amyloid production by lowering free cholesterol levels. The Journal of nutritional biochemistry 15, 749-756. https://doi.org/10.1016/j.jnutbio.2004.06.008

Ying-Jun LU, Jun Z, Shao-min Z, Heng-yi Z, Xiao-xiang Z. 2005. Inhibitory effects of jujuboside A on EEG and hippocampal glutamate in hyperactive rat. Journal of Zhejiang University Science B 6, 265-271.

Yu J, Wang L, Walzem R.L, Miller EG, Pike LM, Patil BS. 2005. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. Journal of agricultural and food chemistry 53, 2009-2014. https://doi.org/10.1021/jf0484632

Yu S, Xu X, Feng J, Liu M, Hu K. 2019. Chitosan and chitosan coating nanoparticles for the treatment of brain disease. International journal of pharmaceutics 560, 282-293. https://doi.org/10.1016/j.ijpharm.2019.02.012

Zaman M.1999. The physico-chemical and biological factors influencing bioadhesion. Biopharm Europe 52-60.

Zanoli P, Avallone R, Baraldi M.1998. Sedative and hypothermic effects induced by β-asarone, a main component of Acorus calamus. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives 12, S114-S116.

Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M. 2006. Curcuminoids enhance amyloid-β uptake by macrophages of Alzheimer’s disease patients. Journal of Alzheimer’s disease 10, 1-7.

 Source: Intra nasal in-situ gel freighted with Nanonaturaceuticals for neurological diseases – from bench to bed side